Blastoid variant of mantle cell lymphoma: late progression from classical mantle cell lymphoma and quantitation of minimal residual disease
Authors:
- 16 March 2005
- journal article
- case report
- Published by Wiley in European Journal of Haematology
- Vol. 74 (4) , 353-358
Abstract
Abstract: Objectives: Classical mantle cell lymphoma (MCL) and its blastoid variant (MCL‐BV) are characterized by an extremely poor prognosis. Long‐time survivors are rare, only very few patients with an overall survival over 10 years have been reported. We present a case of a 41‐year‐old male with a 12 yr history of MCL stage I to show, that very late relapses in MCL are possible and may present as a transformation into an aggressive blastoid variant and to illustrate the value of quantitative minimal residual disease (MRD) monitoring for treatment guidance. Methods: Diagnostic lymph node and bone marrow samples were investigated by immunohistochemistry. Clonality analysis was performed by immunoglobulin heavy chain gene (IGVH) and t(11;14) PCR. The MRD assessment was done by real‐time quantitative PCR (RQ‐PCR) on available follow‐up samples. Results: By histologic review and sequencing of the clonal IGVH and t(11;14) PCR products we demonstrated a common clonal origin of the leucemic MCL‐BV and the classical MCL diagnosed 12 yr earlier. Quantitative MRD assessment revealed significant MRD levels after intensive conventional chemotherapy including Rituximab. Therefore, treatment was early intensified by myeloablative radio‐chemotherapy and allogeneic peripheral stem cell transplantation from an unrelated HLA‐identical donor. This did not translate into a sustained remission as reflected by persisting MRD levels after transplantation and the patient died from rapid progressive disease 3.5 months after transplant. Conclusion: This report presents a rare case of long‐term survivor of MCL with a progression of the original MCL cell clone to MCL‐BV and demonstrates the clinical value of quantitative MRD assessment for optimized therapeutic management.Keywords
This publication has 19 references indexed in Scilit:
- Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936Leukemia, 2003
- Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen)Blood, 2003
- Real-time polymerase chain reaction estimation of bone marrow tumor burden using clonal immunoglobulin heavy chain gene and bcl-1/JH rearrangements in mantle cell lymphomaExperimental Hematology, 2002
- Rituximab and CHOP Induction Therapy for Newly Diagnosed Mantle-Cell Lymphoma: Molecular Complete Responses Are Not Predictive of Progression-Free SurvivalJournal of Clinical Oncology, 2002
- Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtypeLeukemia, 2001
- The impact of autologous stem cell transplantation on the prognosis of mantle cell lymphoma: a joint analysis of two prospective studies with 46 patientsThe Hematology Journal, 2000
- Efficacy of autologous stem cell transplantation in mantle cell lymphoma: a 3-year follow-up studyBone Marrow Transplantation, 2000
- Long-term disease-free survival of patients with advanced mantle-cell lymphoma following high-dose chemotherapyBone Marrow Transplantation, 1998
- The Cytomorphological Spectrum of Mantle Cell Lymphoma is Reflected by Distinct Biological FeaturesLeukemia & Lymphoma, 1998
- Mantle Cell/Centrocytic Lymphoma: Molecular and Phenotypic Analysis Including Analysis of the bcl-1 Major Translocation Cluster by PCR1995